Robert J Coffey

Summary

Country: USA

Publications

  1. ncbi request reprint Not all intrathecal catheter tip MRI findings are inflammatory masses
    Robert J Coffey
    Anesth Analg 104:1600-2; author reply 1602. 2007
  2. ncbi request reprint Neurostimulation for chronic noncancer pain: an evaluation of the clinical evidence and recommendations for future trial designs
    Robert J Coffey
    Medtronic, Inc, Minneapolis, MN, USA
    J Neurosurg 105:175-89. 2006
  3. doi request reprint Medical practice perspective: identification and mitigation of risk factors for mortality associated with intrathecal opioids for non-cancer pain
    Robert J Coffey
    Medtronic Inc, Minneapolis, Minnesota 55432, USA
    Pain Med 11:1001-9. 2010
  4. doi request reprint Mortality associated with implantation and management of intrathecal opioid drug infusion systems to treat noncancer pain
    Robert J Coffey
    Divisions of Neuromodulation Clinical Research, Regulatory Vigilance, and Biostatistics, Medtronic Inc, 7000 Central Avenue NE, Minneapolis, MN 55432, USA
    Anesthesiology 111:881-91. 2009
  5. doi request reprint Intrathecal gabapentin to treat chronic intractable noncancer pain
    Richard Rauck
    Center for Clinical Research, LLC, Carolinas Pain Institute PA, Winston Salem, North Carolina Medtronic, Inc, Minneapolis, Minnesota Medical Pain Clinics, Minneapolis, Minnesota Professor, Department of Anesthesiology, University of California San Diego Medical Center, Pain Medicine, San Diego, California Lifetree Clinical Research and Pain Clinic, Salt Lake City, Utah Napa Pain Institute, Napa, California
    Anesthesiology 119:675-86. 2013
  6. doi request reprint Cerebrospinal fluid pressure measurement in the ovine intrathecal space: a preliminary study towards the diagnosis of intrathecal drug administration catheter dislodgement or occlusion
    Robert J Coffey
    Neuromodulation Clinical and Emerging Therapies, Medtronic, Inc, Minneapolis, Minn, USA robert coffey medtronic com
    Stereotact Funct Neurosurg 88:337-44. 2010
  7. doi request reprint Deep brain stimulation devices: a brief technical history and review
    Robert J Coffey
    Medtronic, Inc, 7000 Central Avenue NE, Minneapolis, MN 55432, USA
    Artif Organs 33:208-20. 2009
  8. ncbi request reprint Inflammatory mass lesions associated with intrathecal drug infusion catheters: report and observations on 41 patients
    Robert J Coffey
    Medtronic, Inc, Minneapolis, Minnesota, USA
    Neurosurgery 50:78-86; discussion 86-7. 2002
  9. ncbi request reprint Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections
    Kenneth A Follett
    Department of Neurosurgery, University of Iowa Hospitals and Clinics, Iowa City, 52242, USA
    Anesthesiology 100:1582-94. 2004
  10. ncbi request reprint "Marchand S, Kupers RC, Bushnell MC, Duncan GH. Analgesic and placebo effects of thalamic stimulation. Pain 2003;105:481-8"
    Robert J Coffey
    Pain 109:522-3; author reply 523-4. 2004

Collaborators

Detail Information

Publications11

  1. ncbi request reprint Not all intrathecal catheter tip MRI findings are inflammatory masses
    Robert J Coffey
    Anesth Analg 104:1600-2; author reply 1602. 2007
  2. ncbi request reprint Neurostimulation for chronic noncancer pain: an evaluation of the clinical evidence and recommendations for future trial designs
    Robert J Coffey
    Medtronic, Inc, Minneapolis, MN, USA
    J Neurosurg 105:175-89. 2006
    ..In light of the risks, efforts, costs, and expectations associated with neurostimulation therapies, a careful reexamination of the methods used to gather evidence for this treatment's long-term efficacy is in order...
  3. doi request reprint Medical practice perspective: identification and mitigation of risk factors for mortality associated with intrathecal opioids for non-cancer pain
    Robert J Coffey
    Medtronic Inc, Minneapolis, Minnesota 55432, USA
    Pain Med 11:1001-9. 2010
    ..Both of those objectives involve judgments, which may be controversial and are subject to practical limitations...
  4. doi request reprint Mortality associated with implantation and management of intrathecal opioid drug infusion systems to treat noncancer pain
    Robert J Coffey
    Divisions of Neuromodulation Clinical Research, Regulatory Vigilance, and Biostatistics, Medtronic Inc, 7000 Central Avenue NE, Minneapolis, MN 55432, USA
    Anesthesiology 111:881-91. 2009
    ..The authors performed investigations to quantify that mortality and compare the results to control populations, including spinal cord stimulation and low back surgery...
  5. doi request reprint Intrathecal gabapentin to treat chronic intractable noncancer pain
    Richard Rauck
    Center for Clinical Research, LLC, Carolinas Pain Institute PA, Winston Salem, North Carolina Medtronic, Inc, Minneapolis, Minnesota Medical Pain Clinics, Minneapolis, Minnesota Professor, Department of Anesthesiology, University of California San Diego Medical Center, Pain Medicine, San Diego, California Lifetree Clinical Research and Pain Clinic, Salt Lake City, Utah Napa Pain Institute, Napa, California
    Anesthesiology 119:675-86. 2013
    ..Its nonopioid properties and presumed spinal site of analgesic action made the study on intrathecal gabapentin attractive to establish the minimum effective dose for a later, pivotal trial...
  6. doi request reprint Cerebrospinal fluid pressure measurement in the ovine intrathecal space: a preliminary study towards the diagnosis of intrathecal drug administration catheter dislodgement or occlusion
    Robert J Coffey
    Neuromodulation Clinical and Emerging Therapies, Medtronic, Inc, Minneapolis, Minn, USA robert coffey medtronic com
    Stereotact Funct Neurosurg 88:337-44. 2010
    ..We determined that normal baseline intrathecal cerebrospinal fluid (CSF) pressure recordings could be obtained in an ovine model and in a catheter dislodgement scenario...
  7. doi request reprint Deep brain stimulation devices: a brief technical history and review
    Robert J Coffey
    Medtronic, Inc, 7000 Central Avenue NE, Minneapolis, MN 55432, USA
    Artif Organs 33:208-20. 2009
    ..We will briefly review the history and present status of DBS from a technical and device-oriented perspective, with an eye toward future advances...
  8. ncbi request reprint Inflammatory mass lesions associated with intrathecal drug infusion catheters: report and observations on 41 patients
    Robert J Coffey
    Medtronic, Inc, Minneapolis, Minnesota, USA
    Neurosurgery 50:78-86; discussion 86-7. 2002
    ..We evaluated the number of patients reported with this condition and whether data support hypotheses that have been put forth regarding the cause of these lesions...
  9. ncbi request reprint Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections
    Kenneth A Follett
    Department of Neurosurgery, University of Iowa Hospitals and Clinics, Iowa City, 52242, USA
    Anesthesiology 100:1582-94. 2004
  10. ncbi request reprint "Marchand S, Kupers RC, Bushnell MC, Duncan GH. Analgesic and placebo effects of thalamic stimulation. Pain 2003;105:481-8"
    Robert J Coffey
    Pain 109:522-3; author reply 523-4. 2004
  11. ncbi request reprint Re: Neurostimulation system used for deep brain stimulation (DBS): MR safety issues and implications of failing to follow safety recommendations
    Robert J Coffey
    Invest Radiol 39:304. 2004